Similar articles for PMID: 25819384

Year	Number of Results
1993	1
1996	2
2001	1
2006	3
2007	1
2008	1
2009	5
2010	7
2011	9
2012	17
2013	24
2014	41
2015	43
2016	38
2017	25
2018	31
2019	25
2020	27
2021	21
2022	12
2023	4
2024	0

1

The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.

Park JS, Lee JS, Kim EY, Jung JY, Kim SK, Chang J, Kim DJ, Lee CY, Jung I, Kim JH, Kim HR, Moon YW, Kim HS, Cho BC, Shim HS. Park JS, et al. Lung Cancer. 2015 Jun;88(3):325-31. doi: 10.1016/j.lungcan.2015.03.002. Epub 2015 Mar 9. Lung Cancer. 2015. PMID: 25819384

2

Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.

Kim HR, Kim DJ, Kang DR, Lee JG, Lim SM, Lee CY, Rha SY, Bae MK, Lee YJ, Kim SH, Ha SJ, Soo RA, Chung KY, Kim JH, Lee JH, Shim HS, Cho BC. Kim HR, et al. J Clin Oncol. 2013 Feb 20;31(6):731-7. doi: 10.1200/JCO.2012.43.8622. Epub 2012 Nov 26. J Clin Oncol. 2013. PMID: 23182986

3

Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer.

Zhang L, Yu H, Badzio A, Boyle TA, Schildhaus HU, Lu X, Dziadziuszko R, Jassem J, Varella-Garcia M, Heasley LE, Kowalewski AA, Ellison K, Chen G, Zhou C, Hirsch FR. Zhang L, et al. J Thorac Oncol. 2015 Jul;10(7):1083-90. doi: 10.1097/JTO.0000000000000562. J Thorac Oncol. 2015. PMID: 26020126 Free PMC article.

4

Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer.

Elakad O, Lois AM, Schmitz K, Yao S, Hugo S, Lukat L, Hinterthaner M, Danner BC, von Hammerstein-Equord A, Reuter-Jessen K, Schildhaus HU, Ströbel P, Bohnenberger H. Elakad O, et al. Cancer Med. 2020 May;9(10):3574-3583. doi: 10.1002/cam4.2994. Epub 2020 Mar 24. Cancer Med. 2020. PMID: 32207251 Free PMC article.

5

Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small-cell lung cancer.

Schultheis AM, Bos M, Schmitz K, Wilsberg L, Binot E, Wolf J, Büttner R, Schildhaus HU. Schultheis AM, et al. Mod Pathol. 2014 Feb;27(2):214-21. doi: 10.1038/modpathol.2013.141. Epub 2013 Jul 26. Mod Pathol. 2014. PMID: 23887299 Free article.

6

Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study.

Lim SH, Sun JM, Choi YL, Kim HR, Ahn S, Lee JY, Lee SH, Ahn JS, Park K, Kim JH, Cho BC, Ahn MJ. Lim SH, et al. Cancer. 2016 Oct;122(19):3024-31. doi: 10.1002/cncr.30135. Epub 2016 Jun 17. Cancer. 2016. PMID: 27315356 Free article. Clinical Trial.

7

Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.

Reck M, Thatcher N, Smit EF, Lorigan P, Szutowicz-Zielinska E, Liepa AM, Winfree KB, Peterson P, Guba SC, Socinski MA. Reck M, et al. Lung Cancer. 2012 Dec;78(3):276-81. doi: 10.1016/j.lungcan.2012.09.002. Epub 2012 Oct 6. Lung Cancer. 2012. PMID: 23043970

8

Prognostic value of fibroblast growth factor receptor 1 gene locus amplification in resected lung squamous cell carcinoma.

Craddock KJ, Ludkovski O, Sykes J, Shepherd FA, Tsao MS. Craddock KJ, et al. J Thorac Oncol. 2013 Nov;8(11):1371-7. doi: 10.1097/JTO.0b013e3182a46fe9. J Thorac Oncol. 2013. PMID: 24077455 Free article.

9

Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer.

Thomas A, Lee JH, Abdullaev Z, Park KS, Pineda M, Saidkhodjaeva L, Miettinen M, Wang Y, Pack SD, Giaccone G. Thomas A, et al. J Thorac Oncol. 2014 Apr;9(4):567-71. doi: 10.1097/JTO.0000000000000089. J Thorac Oncol. 2014. PMID: 24736083 Free PMC article.

10

Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer.

Langer CJ, Albert I, Ross HJ, Kovacs P, Blakely LJ, Pajkos G, Somfay A, Zatloukal P, Kazarnowicz A, Moezi MM, Schreeder MT, Schnyder J, Ao-Baslock A, Pathak AK, Berger MS; GEM017 Investigators. Langer CJ, et al. Lung Cancer. 2014 Sep;85(3):420-8. doi: 10.1016/j.lungcan.2014.05.003. Epub 2014 May 13. Lung Cancer. 2014. PMID: 24997137 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

298 results

Results by year